4//SEC Filing
Orfali May 4
Accession 0001415889-22-000196
CIK 0001821323other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:15 PM ET
Size
5.4 KB
Accession
0001415889-22-000196
Insider Transaction Report
Form 4
Orfali May
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2022-01-03$3.03/sh+10,000$30,300→ 10,000 totalExercise: $3.03Exp: 2032-01-02→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 30% on January 3, 2023 and 70% on January 3, 2024.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001894283
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:15 PM ET
- Size
- 5.4 KB